Thus, while classical IL-6 signaling appears to be closely linked to metabolic diseases and MASLD, the association between IL-6 trans-signaling and MASLD or MASH remains unclear, and the underlying mechanisms remain unknown. Here, IL6 is linked to metabolic dysfunction-associated steatotic liver disease.